Physician

Atul Shah

According to 2025 Medicare claims, Atul Shah (NPI: 1427077270) practices gastroenterology in the Lexington Park, MD market, with the plurality of this provider's patient population coming from Calvert, MD. This provider's primary affiliated billing organization is MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (NPI: 1831592211; TIN: 462691028) and primary practice location at 20678-4057.

Shah's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 833 traditional Medicare patients, billed 3,305 HCPCS/CPT codes, and received $314,402 in Medicare payments. The top billing code was 45384 (Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery). Part D data shows 775 prescription claims across 264 beneficiaries totaling $164,459 in drug costs, led by Linzess (Linaclotide). DME data shows 11 claims. Open Payments data shows 1 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $455,687 to $314,402. Similarly, Part D prescription costs have moved from a higher plateau to a lower plateau, from $454,694 to $164,459. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $151 to $730.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	856	4,403	$455,687
2016	907	4,571	$450,377
2017	866	4,332	$381,659
2018	906	4,171	$394,376
2019	912	3,791	$367,563
2020	706	2,832	$247,638
2021	932	4,050	$412,618
2022	1,014	4,079	$385,083
2023	980	3,468	$353,294
2024	833	3,305	$314,402

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	170	963	$454,694
2016	167	974	$348,768
2017	211	1,046	$320,324
2018	229	999	$711,260
2019	175	713	$311,286
2020	166	706	$186,681
2021	175	613	$186,273
2022	262	702	$159,454
2023	392	843	$249,072
2024	264	775	$164,459

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	57	$756
2016	N/R	53	$652
2017	N/R	N/R	N/R
2018	N/R	23	$2,364
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	11	$611

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
45384	Removal of polyps or growths of large bowel using a flexible endoscope with electrical cautery	239	240	$134
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	263	263	$115
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	423	642	$93
43239	Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope	378	395	$50
45381	Injection beneath lining of large bowel using a flexible endoscope	300	303	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Linzess	Linaclotide	32	2,340	$41,198
Mesalamine	Mesalamine	17	1,470	$4,696
Dexlansoprazole Dr	Dexlansoprazole	11	735	$3,095
Cholestyramine	Cholestyramine (With Sugar)	26	1,434	$2,181
Omeprazole	Omeprazole	132	8,826	$1,592

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0745	Neuromuscular stimulator, electronic shock unit	Y	N/R	11	$611

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$17	Madrigal Pharmaceuticals
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Atul Shah?

Tedicare shows public-source Medicare data for Atul Shah (NPI 1427077270), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Atul Shah have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Atul Shah?

Atul Shah is linked to MEDSTAR MEDICAL GROUP - SOUTHERN MARYLAND LLC (billing NPI 1831592211) in the available physician profile data.

Does Atul Shah have Open Payments data?

Atul Shah has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.